Some suggest splitting doses, others insist on single morning administration
Pharmacokinetic parameters such as AUC, maximum plasma concentration (Cmax), terminal elimination t1/2, volume of distribution (Va), and clearance were calculated [2]
125.7 12.3/80.9 8.2 mmHg, P 0.02), night-to-day ratio for both systolic (89.1 8.5 vs
The break trial represents valuable experiment for any GHK-Cu user completing 6+ month treatment course - discontinuing for 2-3 months reveals how well benefits persist, helps determine whether cycling or continuous use better suits individual biology, provides psychological break from rigid routine, and offers cost savings period while assessing necessity of ongoing application
Self-treatment of chronic wounds without medical supervision is strongly discouraged